Abstract
3-M syndrome is an autosomal-recessive primordial growth disorder characterized by significant intrauterine and postnatal growth restriction. Mutations in the CUL7 gene are known to cause 3-M syndrome. In 3-M syndrome patients that do not carry CUL7 mutations, we performed high-density genome-wide SNP mapping to identify a second locus at 2q35-q36.1. Further haplotype analysis revealed a 1.29 Mb interval in which the underlying gene is located and we subsequently discovered seven distinct null mutations from 10 families within the gene OBSL1. OBSL1 is a putative cytoskeletal adaptor protein that localizes to the nuclear envelope. We were also able to demonstrate that loss of OBSL1 leads to downregulation of CUL7, implying a role for OBSL1 in the maintenance of CUL7 protein levels and suggesting that both proteins are involved within the same molecular pathway. © 2009 The American Society of Human Genetics.
Original language | English |
---|---|
Pages (from-to) | 801-806 |
Number of pages | 5 |
Journal | American Journal of Human Genetics |
Volume | 84 |
Issue number | 6 |
DOIs | |
Publication status | Published - 12 Jun 2009 |
Keywords
- Adolescent
- Cells, Cultured
- Child
- Child, Preschool
- genetics: Cullin Proteins
- antagonists & inhibitors: Cytoskeletal Proteins
- Cytoskeleton
- Female
- genetics: Growth Disorders
- Humans
- Infant
- cytology: Kidney
- Male
- genetics: Mutation
- Oligonucleotide Array Sequence Analysis
- Pedigree
- genetics: Polymorphism, Single Nucleotide
- pharmacology: RNA, Small Interfering
- Syndrome
- Ubiquitination
Fingerprint
Dive into the research topics of 'The Primordial Growth Disorder 3-M Syndrome Connects Ubiquitination to the Cytoskeletal Adaptor OBSL1'. Together they form a unique fingerprint.Impacts
-
Defining the phenotype of severe growth disorders, discovering new genes that control human growth and enhancing clinical practice
Clayton, P. (Participant), Black, G. (Participant), Read, A. (Participant), Manson, F. (Participant), Hanson, D. (Participant) & Patel, L. (Participant)
Impact: Health impacts